# Sibel Blau, M.D. – FDA Inspection, Aug 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/sibel-blau-md/8246e4c0-20ee-48e4-a558-f112f3baf978
Source feed: FDA_Inspections

> FDA inspection 1022119 of Sibel Blau, M.D., August 14, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1022119
- Company Name: Sibel Blau, M.D.
- Inspection Date: 2017-08-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1219328 - 2023-09-15

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.keypedia.com/companies/sibel-blau-md/b4dc81c0-3a20-4088-801f-0a34d1316dad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c